NexGel, Inc. NXGL 深 沪
已收盘 12-19 16:00:00 美东时间
1.62
-0.020
-1.22%
华盛通- 最 高1.67
- 今 开1.66
- 成交量 1.01万股
- 最 低 1.62
- 昨 收 1.64
- 总市值 1319.18万
- 52周最高 4.7385
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.45
- 委 比 -87.35%
- 总股本 814.31万
- 历史最高 5.10
- 量 比 0.12
- 振 幅 3.05%
- 历史最低 1.09
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off and a 5% global royalty in perpetuity on products sold using its drug delivery technology. The Company is spinning off select drug delivery assets into NexGelRx, which will focus on Rx drug delivery solutions using its proprietary hydrogel technology. NEXGEL will remain focused on contract manufacturing and consume...
12-11 13:00
NexGel Inc Cancels Special Stockholder Meeting
NexGel Inc ( ($NXGL) ) has shared an announcement. On November 21, 2025, NexGel...
11-25 05:52
电话会总结 ｜ NEXGEL(NXGL)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据NEXGEL 2025年第三季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第三季度总收入290万美元，同比持平，环比略有增长。其中合同制造业务收入90.7万美元，同比和环比均小幅增长；消费品牌产品收入同比和环比保持稳定。 **盈利能力：** 毛利润124万美元，毛利率42.4%；净亏损65.3万美元，较去年同期69.3万美元的净亏损有所改善。 **现金状况：** 截至9月30日，公司持有现金93.8万美元，受限现金92万美元（与Stada提供的100万美元非稀释性融资相关）。 ## 2. 财务指标变化 **毛
11-12 12:20
NexGel Q3 EPS $(0.08), Inline, Sales $2.930M Miss $3.164M Estimate
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 27.27 percent increase over losses of $(0.11) per share from the same period last year. The company
11-12 05:11
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
11-11 19:11
NEXGEL to Report Third Quarter 2025 Financial Results on November 11th
NEXGEL, Inc. will release its third quarter 2025 financial results after the market close on November 11, 2025. A conference call to discuss the results will be held at 4:30 P.M. ET the same day via phone or webcast. Replay availability through November 25, 2025, with access code 11160116. NEXGEL is a leading provider of healthcare, beauty, and OTC products, specializing in ultra-gentle hydrogel products.
11-03 13:00
NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21
NEXGEL, Inc. announced that CEO Adam Levy will present at the LD Micro Main Event XIX Conference on October 20, 2025, at 11:30 a.m. PT in Track 4 at the Hotel Del Coronado, San Diego. The presentation can be viewed via webcast at [link]. Investors can schedule one-on-one meetings with Mr. Levy by emailing Nexgel@KCSA.com. NEXGEL is a leader in healthcare, beauty, and OTC products, specializing in ultra-gentle hydrogel products. For more informati...
10-09 12:00
CORRECTION: NexGel Q2 EPS $(0.09) Misses $(0.07) Estimate, Sales $2.884M Miss $3.080M Estimate
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 35.71 percent increase over losses of $(0.14) per share from the same
08-13 05:58
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
An Overview of NexGel's Earnings
NexGel (NASDAQ:NXGL) is gearing up to announce its quarterly earnings on Tuesda...
08-12 03:04
